News of the company VaxGen - Brisbane, CA, United States of America

Current News

Overview

Companies

Countries

Tag Clouds

0-9

�

Article 1 to 3 out of 3 concerning VaxGen Inc.

VaxGen Raises USD 79M Through Sale of Interest in Overseas Biopharmaceutical Manufacturing Facility (06/30/2006)
VaxGen, Inc. announced that it has realized gross proceeds of approximately USD 79.0 million through the sale of a portion of its common shares in Celltrion, Inc. VaxGen also granted the purchasers an exclusive option to acquire the remainder of its ...

more information
�
VaxGen Concludes Early Stage Meningitis B Vaccine Collaboration with EndoBiologics (06/01/2006)
VaxGen, Inc. announced that it is ending a collaboration with EndoBiologics International Corp. VaxGen announced in May 2005 that it would fund proof-of-concept studies and then determine whether to pursue commercial development of the vaccine ...

more information
�
VaxGen and BD to Jointly Evaluate Novel Dermal Injection Technology for Delivery of VaxGen's Anthrax Vaccine (02/24/2006)
VaxGen, Inc. announced that they have entered into an agreement with BD (Becton, Dickinson and Company) on a program to evaluate the potential advantages of using BD's Micro Injection technology to deliver VaxGen's recombinant anthrax vaccine ...

more information
�

Current NewsRSS